Skip to content

Gross margin at other companies

Danaher logo
DanaherDHR
58.9%-0.8pp
Agilent Technologies logo
Agilent TechnologiesA
52.7%-0.6pp
Illumina logo
IlluminaILMN
66.2%-0.1pp
TEC
Bio-TechneTECH
65%-0.8pp
10x Genomics, Inc. logo
10x Genomics, Inc.TXG
69.6%+1.2pp
Bio-Rad Laboratories logo
Bio-Rad LaboratoriesBIO
51.9%-1.6pp

Other financials

Income statement

See full
Revenue$110.7M+19.3%
Gross profit$57.1M+24.1%
Operating income-$45.9M-10.4%
Net income-$44.0M-11.9%
EPS (diluted)-$0.71-7.6%

Balance sheet

See full
Cash & equivalents$124.9M-41.4%
Total debt$110.8M+16.3%
Total equity$455.1M+3.4%
Total assets$676.2M+13.5%

Cash flow

See full
Operating cash flow-$17.6M-35.2%
CapEx$7.9M+90.3%
Free cash flow-$25.4M-48.5%

Valuation

See full
Market cap$5.45B+24.4%

Profitability

See full
Operating margin-33.9%-9.9pp
Net margin-19.8%-7.7pp
FCF margin-23.2%+7.0pp

Returns & leverage

See full
Return on equity-18.2%-6.3pp
Debt / equity0.2×0.0×
Current ratio2.7×-1.8×

Where this comes from

Calculated from Twist Bioscience Corporation’s reported figures.

Based on trailing twelve months.

The official record: Twist Bioscience Corporation’s 10-Q, filed May 4, 2026, on SEC EDGAR. View the filing →

Ask your AI about Twist Bioscience Corporation's gross margin.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Twist Bioscience Corporation's gross margin?
Twist Bioscience Corporation (TWST) reported gross margin of 52.1% in Q1 2026.
How has Twist Bioscience Corporation's gross margin changed year-over-year?
Twist Bioscience Corporation's gross margin increased by 11.5% year-over-year, from 46.7% to 52.1%.
What is the long-term trend for Twist Bioscience Corporation's gross margin?
Over 5 years (2020 to 2025), Twist Bioscience Corporation's gross margin has grown at a 9.8% compound annual growth rate (CAGR), from 31.8% to 50.7%.
What does gross margin mean?
Gross profit (revenue minus cost of revenue) as a percentage of revenue, on a trailing-twelve-month basis. Measures how much of each sales dollar survives the direct cost of producing the goods or services sold.